(Q82029406)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808925%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

Clinical features, pathophysiology and treatment of dementia associated with Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808925%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

1 reference

Murat Emre

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808925%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808925%20AND%20SRC:MED&resulttype=core&format=json

Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn

14 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808925%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808925%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

401-419

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808925%20AND%20SRC:MED&resulttype=core&format=json

Frequency of dementia in Parkinson disease.

14 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Risk of dementia in Parkinson's disease: a community-based, prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Fluctuations in attention: PD dementia vs DLB with parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Successful use of donepezil for the treatment of psychotic symptoms in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

rCBF SPECT in Parkinson's disease patients with mental dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Staging of brain pathology related to sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Use of functional imaging in Parkinsonism and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Which factors predict cognitive decline in Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Parkinson's disease and dementia: norepinephrine and dopamine in locus ceruleus

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Alpha-synuclein locus duplication as a cause of familial Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Lewy body cortical involvement may not always predict dementia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Visual-spatial ability in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Intellectual impairment in Parkinson's disease: clinical, pathologic, and biochemical correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Alzheimer's disease and Parkinson's disease: Comparison of speech and language alterations

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

'Lewy body disease': clinico-pathological correlations in 18 consecutive cases of Parkinson's disease with and without dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

A subcortico-cortical cholinergic system is affected in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Clinical features predicting dementia in idiopathic Parkinson's disease: a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Dementia associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

What causes mental dysfunction in Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Rivastigmine for dementia associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Donepezil in the treatment of hallucinations and delusions in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Longitudinal outcome of Parkinson's disease patients with psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Long‐term outcome of quetiapine use for psychosis among parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Regional cerebral blood flow in Parkinson's disease with and without dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

The heterogeneity of idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Atypical antipsychotics in Parkinson-sensitive populations

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Dementia in idiopathic Parkinson's disease. A neuropathological study of 32 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Rivastigmine (Exelon) for dementia in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Dementia and cognitive impairment in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Development of daytime somnolence over time in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Early dopaminergic drug-induced hallucinations in parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Sentence comprehension and praxis deficits in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Sentence comprehension in Parkinson's disease: The role of attention and memory

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

APOE and the risk of PD with or without dementia in a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Recall and recognition memory in patients with Alzheimer's and Parkinson's diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Different error pattern of episodic and semantic memory in Alzheimer's disease and Parkinson's disease with dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Tremor at onset. Predictor of cognitive and motor outcome in Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

The effect of age of disease onset on neuropsychological performance in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Relationship of motor symptoms, intellectual impairment, and depression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Neuropsychological differences between the dementias of Alzheimer's and Parkinson's diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Magnetic resonance imaging in dementia of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

A clinicopathologic study of 100 cases of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Cholinesterase inhibition in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Apolipoprotein E4 in Parkinson Disease and Dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-L-dopa PET study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Neuropsychological characteristics of preclinical dementia in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Morphological substrates of dementia in parkinsonism. A critical update.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Clinico-pathological correlations in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Loss of response to levodopa in Parkinson's disease and co-occurrence with dementia: role of D3 and not D2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Autonomic failure in neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Cerebral Blood Flow and Dementia in Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Working memory in mild Alzheimer's disease and early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

The beneficial effect of donepezil on visual hallucinations in three patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Visuospatial impairment in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Motor impairment in PD: relationship to incident dementia and age.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Do risk factors for Alzheimer's disease predict dementia in Parkinson's disease? An exploratory study.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Combined effect of age and severity on the risk of dementia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Lack of Familial Aggregation of Parkinson Disease and Alzheimer Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Deposition of amyloid (A4) protein within the brains of persons with dementing disorders other than Alzheimer's disease and Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Are demented patients with Parkinson's disease accurately reflected in prevalence surveys? A survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

The Frequency and Associated Risk Factors for Dementia in Patients With Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Epidemiology of Parkinson's disease in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

"Tip-of-the-tongue" phenomenon in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

An estimate of the prevalence of dementia in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

An estimate of the incidence of dementia in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

A Population-Based Investigation of Parkinson's Disease With and Without Dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

A controlled study of dementia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Selective deficits in Alzheimer and parkinsonian dementia: visuospatial function

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Relationship of motor symptoms to intellectual deficits in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Visual perception in Parkinson disease dementia and dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Olanzapine treatment for dopaminergic-induced hallucinations

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Cognitive slowing in Parkinson's and Alzheimer's patients: distinguishing bradyphrenia from dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Cerebral glucose metabolism in Parkinson's disease with and without dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Deficit of verb generation in nondemented patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: preliminary findings from an open trial

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

A longitudinal of Parkinson's disease: clinical and neuropsychological correlates of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Parkinson's disease: the thalamic components of the limbic loop are severely impaired by alpha-synuclein immunopositive inclusion body pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

SPECT findings in Parkinson's disease associated with dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Parkinson's disease and dementia with Lewy bodies: a difference in dose?

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

alpha-Synuclein locus triplication causes Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

(99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Perceptual motor dysfunction in Parkinson's disease: a deficit in sequential and predictive voluntary movement

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Antecedent clinical features associated with dementia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Dementia in Parkinson disease: a proton magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Cholinergic dysfunction in diseases with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Side of onset of motor symptoms influences cognition in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

The beneficial effect of cholinesterase inhibitors on patients suffering from Parkinson's disease and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Basal forebrain neurons in the dementia of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

The heterogeneity of Parkinson's disease: clinical and prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

The locus ceruleus and dementia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2983018-1

7 January 2021

10.1016/S0072-9752(07)83018-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808925%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference